Hepatitis C: all 2,356 studies
Page 12 of 24. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.
- Community Access, Retention in Care, and Engagement for Hepatitis C TreatmentCompletedNCT03581383Not applicable
- Simplified Antiviral Treatment Strategy for Hepatitis C in MyanmarCompletedNCT03579576
- Eight Weeks of Elbasvir/Grazoprevir in the Treatment of HCV Genotype 4CompletedNCT03578640Phase 3
- Transmission of Chronic Hepatitis C in PregnancyCompletedNCT03570112
- Autoantibodies and Direct-acting AntiviralsCompletedNCT03566966
- Epidemiology of Chronic Hepatitis C and Disease ModellingCompletedNCT03566563
- Examining Hepatitis C Reinfection Rates in KenyaCompletedNCT03564639
- Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 TrialStatus unknownNCT03551444Phase 3
- Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San DiegoStatus unknownNCT03551002
- Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution TherapyStatus unknownNCT03549312Phase 4
- Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C VirusStatus unknownNCT03540212Phase 2/3
- DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C)CompletedNCT03537196Phase 4
- DRug Use and Infections in Hai Phong ViEtnam Among Persons Who Inject DrugsCompletedNCT03526939
- HepCare: The Effectiveness of Community Based Interventions With Peer Support to Improve Case Detection, Carry Out Pre-treatment Assessments and Assist Underserved Populations Through HCV TreatmentStatus unknownNCT03524794
- People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral AgentsActive, not recruitingNCT03520660Phase 4
- Evaluation of Multiple HCV Diagnosis Pathways for Efficacy, Cost Effectiveness and Cure in NHS TaysideCompletedNCT03513796
- Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole.CompletedNCT03513393Phase 1
- "Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in EgyptStatus unknownNCT03510637
- Changes in Cognition in HCV Patients After Virus Eradication With Direct Antiviral AgentsCompletedNCT03508115
- Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)TerminatedNCT03500562
- Sysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral InfectionsStatus unknownNCT03495570
- A TEst and Treat Intervention aMong Current People Who Inject Drugs With HCV Attending Needle and Syringe PrOgramsCompletedNCT03492112Not applicable
- Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir CombinationCompletedNCT03490097Phase 2/3
- Management of Patients With Hepatitis C in a Public Health Care Setting: The Punjab ModelStatus unknownNCT03488485Not applicable
- Phase 3 Study of Yimitasvir Phosphate CapsulesCompletedNCT03487107Phase 3
- Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patients With Chronic Hepatitis C Genotype 1bCompletedNCT03485846Phase 2
- Re-treatment of HCV Following DAA FailureTerminatedNCT03483987Not applicable
- Pilot Trial of Directly Observed Anti HCV Therapy & Contingency Management in a Population on Opiate Substitute TherapyCompletedNCT03483818Not applicable
- Crowdsourcing to Promote HBV and HCV Testing in ChinaCompletedNCT03482388Not applicable
- DAA Therapy in Pediatric Patients With Chronic Hepatitis CStatus unknownNCT03481036Not applicable
- Pathology of Hepatitis c NephropathyStatus unknownNCT03476031
- International Validation of a Sexual Quality of Life Questionnaire Specific to HIV and Hepatitis C (PROQOL-SexLife)CompletedNCT03468673
- The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults SubjectsCompletedNCT03462173Phase 1
- Chronic Hepatitis C in Chronic Hemodialysis Recipients - An Observational StudyStatus unknownNCT03461250
- Cohort Study on People Who Inject Drugs in SenegalStatus unknownNCT03459768
- Phase 2 Study of Yimitasvir Phosphate CapsulesCompletedNCT03458481Phase 2
- The Use of MRI Apparent Diffusion Coefficient Value (ADC Value) to Assess Liver CirrhosisStatus unknownNCT03456440
- Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis CCompletedNCT03453346Not applicable
- Study of HIV, HCV, APS and Phylogenetics for PWIDCompletedNCT03447210Not applicable
- Effect of Direct-acting Antiviral Drugs on Erectile FunctionStatus unknownNCT03444272Phase 3
- Registry-based HCV Care Cascade Navigation at Atlanta's Grady Memorial HospitalTerminatedNCT03441542Not applicable
- Liver Elastography in Patients Undergoing Treatment for Hepatitis CStatus unknownNCT03434470
- Grazoprevir and Elbasvir Without Ribavirin for 12 Weeks in Patients With HCV-related Cryoglobulinemic NephropathyStatus unknownNCT03433326
- A Study to Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in ChinaCompletedNCT03430830Phase 1
- Clinical Profile of Parkinson's Disease in Patients With Hepatitis C InfectionStatus unknownNCT03420573
- The Staying Safe InterventionStatus unknownNCT03418636Not applicable
- Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis CCompletedNCT03416491Phase 2
- Effect of Implementation Of Outreach Behavioral Change Program for HCV EliminationCompletedNCT03415334Not applicable
- Prevalence of IL28B Polymorphism in Hepatitis C PatientsCompletedNCT03415009
- Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected PatientsCompletedNCT03413696
- Hepatitis C (HCV) Cure and Kidney HealthStatus unknownNCT03407703
- Counseling Hepatitis C Virus (HCV) Positive Patients for Cardiovascular Disease Risk FactorsCompletedNCT03402334Not applicable
- Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis CStatus unknownNCT03402165Phase 4
- Eliminating Hepatitis C VirusCompletedNCT03401697
- Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4WithdrawnNCT03381859Phase 4
- Expanding the Pool in Lung TransplantationCompletedNCT03377478Phase 1
- Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency VirusCompletedNCT03369327Phase 3
- Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based RegimensCompletedNCT03366610
- Toward Elimination of Hepatitis C Virus (HCV): A Pilot StudyStatus unknownNCT03364725Phase 4
- Epidemiology of Hepatitis B, C and Delta in Reunion IslandStatus unknownNCT03362866
- Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.CompletedNCT03362814Phase 2/3
- Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney TransplantStatus unknownNCT03359746Phase 4
- Evaluating Treatment as Prevention Among People Who Inject Drugs in Dundee for HCVCompletedNCT03356405
- Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment EfficacyCompletedNCT03348059
- Side Effects After Direct-acting Antiviral TreatmentCompletedNCT03346941
- Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based SettingsCompletedNCT03343925
- Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C AdolescentsStatus unknownNCT03343444Phase 3
- Benefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed CryoglobulinemiaCompletedNCT03342261
- Evaluation of Treatment of Chronic HCV Patients in Chronic Kidney Disease Versus End Stage Renal Disease PatientsCompletedNCT03341988Phase 1
- Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6CompletedNCT03341871
- Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCVCompletedNCT03324633
- Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2CompletedNCT03320889Not applicable
- Impact of Sofosbuvir and Daclatasvir Concentration on HCV RNACompletedNCT03318887
- Hepatitis C Screening in the Primary Care SettingCompletedNCT03316313
- HCV Post-Exposure Prophylaxis for Health Care WorkersWithdrawnNCT03313414Phase 4
- Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-relatedCompletedNCT03313154
- Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6CompletedNCT03303599
- A Self-efficAcy Intervention to reDuce Injecting Risk behAviour and hePatitis c reinfecTion RatesCompletedNCT03293576Not applicable
- Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in BordeauxCompletedNCT03290755
- Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without RibavirinCompletedNCT03283176
- Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients.WithdrawnNCT03279133Phase 4
- Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C VirusCompletedNCT03276039
- Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral DrugsStatus unknownNCT03268317
- Detection of Hepatitis C Infection by Oraquick Test Among Health Care WorkersStatus unknownNCT03254901
- Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological ResponseCompletedNCT03254121
- A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus InfectionTerminatedNCT03253471Phase 1
- Integrating HIV and Hepatitis C Screening in an Urban Emergency DepartmentCompletedNCT03252483Not applicable
- Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected PatientsCompletedNCT03250910Phase 4
- Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative RecipientsCompletedNCT03249194Early Phase 1
- Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C InfectionCompletedNCT03248622
- Study of the Early Occurrence of Hepatocellular Carcinoma (HCC) in Egyptian HCV Infected Patients Receiving Sofosbuvir and DaclatasvirStatus unknownNCT03247296
- Long Term Follow-up of Hepatitis C Cured PatientsCompletedNCT03246048
- Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1CompletedNCT03245931
- HCV Group Evaluation and Treatment Uptake (HCV GET-UP) InterventionCompletedNCT03242655Not applicable
- Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.Status unknownNCT03241823
- Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC) Pilot StudyCompletedNCT03231930Not applicable
- Effects of Direct Antiviral Agents on Hepatitis C Virus ArthropathyStatus unknownNCT03226717
- Transforming the Cascade Of Hepatitis C CareCompletedNCT03226509
- Expanding the Pool in Orthotopic Heart TransplantationCompletedNCT03222531Phase 2
- Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1bStatus unknownNCT03222167Phase 3